Johnson & Johnson to acquire V-Wave for up to $1.7 billion

Johnson & Johnson has entered into a definitive agreement to acquire V-Wave Ltd., a developer of heart failure treatment devices, for an upfront payment of $600 million plus potential milestone payments up to approximately $1.1 billion. V-Wave's Ventura Interatrial Shunt is designed to treat heart failure.

“The planned acquisition of V-Wave will extend Johnson & Johnson MedTech’s position as an innovation leader in addressing cardiovascular disease.”jnjmedtech.com

• 1 source
• jnjmedtech.comJohnson & Johnson to Acquire V-Wave | J&J MedTechAug 20, 2024

Summarized from public sources; check the original articles before acting on it.